New RSV Vaccine Clinical Trial
Receive the annual flu vaccine and an investigational RSV vaccine
📢 We are investigating a potential new vaccine for Respiratory Syncytial Virus (RSV)
In order to be considered to take part in the study, you’ll need to meet all of the following (and some other specific criteria):
✔️ You are aged 65 or over
✔️ You are generally healthy or have stable chronic health conditions
If that sounds like you, we would like to invite you to take part in our latest study investigating a potential vaccine!
All participants in this study will receive the annual flu vaccine and the investigational RSV vaccine.
Click here or scroll down to learn about this study's inclusion criteria ⬇️
If you take part in the research study:
Receive the annual flu vaccine and the investigational RSV vaccine
Reimbursement of costs
For out-of-pocket expenses, such as travel and parking
No overnight stays!
All study visits are out-patient only
Meet new people
Help your community
Advance medical science
Do your part to potentially advance breakthroughs in clinical research
🏥 Study Guide
Who can take part in this study?
In order to be eligible to participate in the study, you must meet all of the following (and some other specific criteria):
- You are aged 65 or over
- You are generally healthy, or you have a stable chronic disease
Who is unable to take part in this study?
Unfortunately, if you meet any of the following, this study is not the right fit for you:
- Anyone who has already received an RSV vaccine at any time, or a flu vaccine in the past 6 months
- Anyone who has a known or suspected condition that weakens their immune system
How long will the study take?
If you agree to take part, and the study is suitable for you, your participation in the study is expected to be approximately 2 months. This includes blood tests and other study procedures:
- Two outpatient visits to the clinic for:
- Your annual flu vaccination
- The study’s investigational vaccine
- A placebo
- One follow-up outpatient visit
What is Respiratory Syncytial Virus (RSV)?
RSV is a common respiratory virus which affects the lungs and the smaller passageways that carry air to the lungs. RSV is one of the most common causes of childhood illness, infecting most children by two years of age, however RSV can also infect adults.
Severe infection with RSV can lead to pneumonia (an infection in the lungs) and bronchiolitis (inflammation of the small airways in the lungs) and may require hospitalisation. People at greatest risk of severe infection are the very young (those less than six months old), those over the age of 65 and those of any age who have heart or lung conditions or a weakened immune system.
Where is my nearest study site?
Here is a list of all of the sites that are currently recruiting for this study:
- Bruce - Paratus Clinical Research Bruce, Canberra
New South Wales
- Blacktown - Paratus Clinical Research Western Sydney
- Botany - Emeritus Research
- Broadmeadow - Genesis Research Services
- Brookevale- Northern Beaches Clinical Research
- Coffs Harbour - Northside Health
- Darlinghurst - Holdsworth House Medical Practice
- Kanwal - Paratus Clinical Research Central Coast
- New Lambton Heights - John Hunter Hospital
- Randwick-Scientia Clinical Research
- Westmead - Westmead Hospital
- Albion - Paratus Clinical Research Brisbane
- Herston- Nucleus Network
- Mackay - Mackay Base Hospital
- Milton- Core Research Group
- Morayfield- University of Sunshine Coast
- Sippy Downs- University of Sunshine Coast
- Southport - Griffith University Clinical Trial Unit
- Taringa - AusTrials Taringa
- Tarragindi - Austrials Wellers Hill
- Norwood - CMAX Travel Bug Vaccination Clinic
- Para Hills West - CMAX McIntyre Medical Centre)
- Hobart - University of Tasmania
- Box Hill - Box Hill Hospital
- Camberwell- Emeritus Research
- Melbourne- Nucleus Network
- Nedlands - Institute for Respiratory Health
- Spearwood - Latitude Clinical Research
What if I have other questions about the study?
We are here for you! Click or tap this button to send an email to our Patient Experience team: